Conference Reports for NATAP

Back

19th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV     Rate of Progression to Osteoporosis in a Large Cohort of HIV-Infected Subjects. - (11/02/17)   Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on Telomere Length Attrition in a Prospective Cohort of Aviremic HIV-Infected Participants - (11/10/17)   RETROSPECTIVE OBSERVATIONAL STUDY TO DEFINE THE PREVALENCE OF SARCOPENIA IN HIV-INFECTED PATIENTS - (11/10/17)   Intrahepatic triglyceride is more strongly associated with insulin-resistant glucose metabolism than visceral adiposity in HIV, and is improved with tauroursodeoxycholic acid (TUDCA) treatment - (11/10/17)   Bone Mineral Density in a Cohort of Young Adult Women using Depo-provera and Tenofovir, Kampala, Uganda - (11/10/17)   Bone density, microarchitecture and tissue quality after 48-weeks and 96-weeks of treatment with Tenofovir Disoproxil Fumarate. - (11/10/17)   Analysis of serum metabolomics parameters associated with carotid intima-media thickness (c-IMT) and inflammation in HIV-infected, never-smoker men, naïve of ART or ART-controlled, compared to matched HIV-negative controls. - (11/10/17)   A Randomized, Double-Blinded, Placebo-Controlled Trial of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed HIV Infection ACTG 5346 - (11/10/17)   Patterns of Co-occurring Comorbidities in People Living with HIV - (11/10/17)   Utility of chronic kidney disease (CKD) risk prediction scores and the changing - prevalence of CKD has doubled from '09 to '15; risk scores are predictive - (11/06/17)   Effect of Vitamin D Supplementation on Bone Turnover Markers (BTMs) During HIV Pre-Exposure Prophylaxis (PrEP) Using Tenofovir Disoproxil Fumarate-Emtricitabine (TDF-FTC) in Men who Have Sex with Men (MSM) A Matched Case-Control Substudy of CCTG 595 - (11/06/17)   Impact of Antiretroviral Treatment Containing Tenofovir Difumarate on Telomere Length Attrition in a Prospective Cohort of Aviremic HIV-Infected Participants - (11/06/17)   Associations Between Subcutaneous Fat Density and Metabolic and Inflammatory Biomarkers Differ by HIV Serostatus and Are Independent of Fat Quantity - (11/06/17)   Alterations of adipose tissue induced by HIV or SIV infection: Tat and Nef-induced senescence and fibrosis - (11/04/17)   Frailty Predicts Recurrent but Not Single Falls 10 Years Later in HIV+ and HIV- Women - (11/04/17)   Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID Cohort - (11/04/17)